Andrographolide suppresses endothelial cell apoptosis via activation of phosphatidyl inositol-3-kinase/Akt pathway

Jiun H. Chen, George Hsiao, An Rong Lee, Chin Chen Wu, Mao Hsiung Yen

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Andrographolide (Andro), an active component isolated from the Chinese official herbal Andrographis paniculata, which has been reported to prevent oxygen radical production and thus prevent inflammatory diseases. In this study, we investigated the molecular mechanisms and signaling pathways by which Andro protects human umbilical vein endothelial cells (HUVECs) from growth factor (GF) deprivation-induced apoptosis. Results demonstrated that HUVECs undergo apoptosis after 18hr of GF deprivation but that this cell death was suppressed by the addition of Andro in a concentration-dependent manner (1-100μM). Andro suppresses the mitochondrial pathway of apoptosis by inhibiting release of cytochrome c into the cytoplasm and dissipation of mitochondrial potential (Δψm), as a consequence, prevented caspase-3 and -9 activation. Treatment of endothelial cells with Andro-induced activation of the protein kinase Akt, an anti-apoptotic signal, and phosphorylation of BAD, a down-stream target of Akt. Suppression of Akt activity by wortmannin, by LY-294002 and by using a dominant negative Akt mutant abolished the anti-apoptotic effect of Andro. In contrast, the ERK1/2 activities were not affected by Andro. The ERK1/2 inhibitor, PD98059 failed to antagonize the protective effect of Andro. In conclusion, Andro exerts its anti-apoptotic potential via activation of the Akt-BAD pathway in HUVECs and thus may represent a candidate of therapeutic agent for atherosclerosis.

Original languageEnglish
Pages (from-to)1337-1345
Number of pages9
JournalBiochemical Pharmacology
Volume67
Issue number7
DOIs
Publication statusPublished - Apr 1 2004

Fingerprint

Endothelial cells
Phosphatidylinositols
Phosphotransferases
Endothelial Cells
Chemical activation
Apoptosis
Human Umbilical Vein Endothelial Cells
Intercellular Signaling Peptides and Proteins
Andrographis
Endothelial Growth Factors
andrographolide
Phosphorylation
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Caspase 9
Cell death
Cytochromes c
Caspase 3
Protein Kinases
Reactive Oxygen Species
Atherosclerosis

Keywords

  • Andro
  • Andrographolide
  • ERK
  • Extracellular regulated kinase
  • GF
  • Growth factor
  • Human umbilical vein endothelial cells
  • HUVECs
  • NFκB
  • Nitric oxide synthase
  • NOS
  • Phosphatidylinositol 3-kinase
  • PI3K
  • Reactive oxygen species
  • ROS
  • SMCs
  • Smooth muscle cells

ASJC Scopus subject areas

  • Pharmacology

Cite this

Andrographolide suppresses endothelial cell apoptosis via activation of phosphatidyl inositol-3-kinase/Akt pathway. / Chen, Jiun H.; Hsiao, George; Lee, An Rong; Wu, Chin Chen; Yen, Mao Hsiung.

In: Biochemical Pharmacology, Vol. 67, No. 7, 01.04.2004, p. 1337-1345.

Research output: Contribution to journalArticle

Chen, Jiun H. ; Hsiao, George ; Lee, An Rong ; Wu, Chin Chen ; Yen, Mao Hsiung. / Andrographolide suppresses endothelial cell apoptosis via activation of phosphatidyl inositol-3-kinase/Akt pathway. In: Biochemical Pharmacology. 2004 ; Vol. 67, No. 7. pp. 1337-1345.
@article{a7cdd8547f5c4656baa80126f8a7cf12,
title = "Andrographolide suppresses endothelial cell apoptosis via activation of phosphatidyl inositol-3-kinase/Akt pathway",
abstract = "Andrographolide (Andro), an active component isolated from the Chinese official herbal Andrographis paniculata, which has been reported to prevent oxygen radical production and thus prevent inflammatory diseases. In this study, we investigated the molecular mechanisms and signaling pathways by which Andro protects human umbilical vein endothelial cells (HUVECs) from growth factor (GF) deprivation-induced apoptosis. Results demonstrated that HUVECs undergo apoptosis after 18hr of GF deprivation but that this cell death was suppressed by the addition of Andro in a concentration-dependent manner (1-100μM). Andro suppresses the mitochondrial pathway of apoptosis by inhibiting release of cytochrome c into the cytoplasm and dissipation of mitochondrial potential (Δψm), as a consequence, prevented caspase-3 and -9 activation. Treatment of endothelial cells with Andro-induced activation of the protein kinase Akt, an anti-apoptotic signal, and phosphorylation of BAD, a down-stream target of Akt. Suppression of Akt activity by wortmannin, by LY-294002 and by using a dominant negative Akt mutant abolished the anti-apoptotic effect of Andro. In contrast, the ERK1/2 activities were not affected by Andro. The ERK1/2 inhibitor, PD98059 failed to antagonize the protective effect of Andro. In conclusion, Andro exerts its anti-apoptotic potential via activation of the Akt-BAD pathway in HUVECs and thus may represent a candidate of therapeutic agent for atherosclerosis.",
keywords = "Andro, Andrographolide, ERK, Extracellular regulated kinase, GF, Growth factor, Human umbilical vein endothelial cells, HUVECs, NFκB, Nitric oxide synthase, NOS, Phosphatidylinositol 3-kinase, PI3K, Reactive oxygen species, ROS, SMCs, Smooth muscle cells",
author = "Chen, {Jiun H.} and George Hsiao and Lee, {An Rong} and Wu, {Chin Chen} and Yen, {Mao Hsiung}",
year = "2004",
month = "4",
day = "1",
doi = "10.1016/j.bcp.2003.12.015",
language = "English",
volume = "67",
pages = "1337--1345",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Andrographolide suppresses endothelial cell apoptosis via activation of phosphatidyl inositol-3-kinase/Akt pathway

AU - Chen, Jiun H.

AU - Hsiao, George

AU - Lee, An Rong

AU - Wu, Chin Chen

AU - Yen, Mao Hsiung

PY - 2004/4/1

Y1 - 2004/4/1

N2 - Andrographolide (Andro), an active component isolated from the Chinese official herbal Andrographis paniculata, which has been reported to prevent oxygen radical production and thus prevent inflammatory diseases. In this study, we investigated the molecular mechanisms and signaling pathways by which Andro protects human umbilical vein endothelial cells (HUVECs) from growth factor (GF) deprivation-induced apoptosis. Results demonstrated that HUVECs undergo apoptosis after 18hr of GF deprivation but that this cell death was suppressed by the addition of Andro in a concentration-dependent manner (1-100μM). Andro suppresses the mitochondrial pathway of apoptosis by inhibiting release of cytochrome c into the cytoplasm and dissipation of mitochondrial potential (Δψm), as a consequence, prevented caspase-3 and -9 activation. Treatment of endothelial cells with Andro-induced activation of the protein kinase Akt, an anti-apoptotic signal, and phosphorylation of BAD, a down-stream target of Akt. Suppression of Akt activity by wortmannin, by LY-294002 and by using a dominant negative Akt mutant abolished the anti-apoptotic effect of Andro. In contrast, the ERK1/2 activities were not affected by Andro. The ERK1/2 inhibitor, PD98059 failed to antagonize the protective effect of Andro. In conclusion, Andro exerts its anti-apoptotic potential via activation of the Akt-BAD pathway in HUVECs and thus may represent a candidate of therapeutic agent for atherosclerosis.

AB - Andrographolide (Andro), an active component isolated from the Chinese official herbal Andrographis paniculata, which has been reported to prevent oxygen radical production and thus prevent inflammatory diseases. In this study, we investigated the molecular mechanisms and signaling pathways by which Andro protects human umbilical vein endothelial cells (HUVECs) from growth factor (GF) deprivation-induced apoptosis. Results demonstrated that HUVECs undergo apoptosis after 18hr of GF deprivation but that this cell death was suppressed by the addition of Andro in a concentration-dependent manner (1-100μM). Andro suppresses the mitochondrial pathway of apoptosis by inhibiting release of cytochrome c into the cytoplasm and dissipation of mitochondrial potential (Δψm), as a consequence, prevented caspase-3 and -9 activation. Treatment of endothelial cells with Andro-induced activation of the protein kinase Akt, an anti-apoptotic signal, and phosphorylation of BAD, a down-stream target of Akt. Suppression of Akt activity by wortmannin, by LY-294002 and by using a dominant negative Akt mutant abolished the anti-apoptotic effect of Andro. In contrast, the ERK1/2 activities were not affected by Andro. The ERK1/2 inhibitor, PD98059 failed to antagonize the protective effect of Andro. In conclusion, Andro exerts its anti-apoptotic potential via activation of the Akt-BAD pathway in HUVECs and thus may represent a candidate of therapeutic agent for atherosclerosis.

KW - Andro

KW - Andrographolide

KW - ERK

KW - Extracellular regulated kinase

KW - GF

KW - Growth factor

KW - Human umbilical vein endothelial cells

KW - HUVECs

KW - NFκB

KW - Nitric oxide synthase

KW - NOS

KW - Phosphatidylinositol 3-kinase

KW - PI3K

KW - Reactive oxygen species

KW - ROS

KW - SMCs

KW - Smooth muscle cells

UR - http://www.scopus.com/inward/record.url?scp=1542345739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542345739&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2003.12.015

DO - 10.1016/j.bcp.2003.12.015

M3 - Article

C2 - 15013849

AN - SCOPUS:1542345739

VL - 67

SP - 1337

EP - 1345

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 7

ER -